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Single molecule and multiple bond 
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Ying Bena Lim1,2, Juzar Thingna2,3, Jianshu Cao2,3 & Chwee Teck Lim1,2,4
The adhesion of malaria infected red blood cells (iRBCs) to host endothelial receptors in the 
microvasculature, or cytoadhesion, is associated with severe disease pathology such as multiple organ 
failure and cerebral malaria. Malaria iRBCs have been shown to bind to several receptors, of which 
intercellular adhesion molecule 1 (ICAM-1) upregulation in brain microvasculature is the only one 
correlated to cerebral malaria. We utilize a biophysical approach to study the interactions between 
iRBCs and ICAM-1. At the single molecule level, force spectroscopy experiments reveal that ICAM-1 
forms catch bond interactions with Plasmodium falciparum parasite iRBCs. Flow experiments are 
subsequently conducted to understand multiple bond behavior. Using a robust model that smoothly 
transitions between our single and multiple bond results, we conclusively demonstrate that the catch 
bond behavior persists even under flow conditions. The parameters extracted from these experimental 
results revealed that the rate of association of iRBC-ICAM-1 bonds are ten times lower than iRBC-CD36 
(cluster of differentiation 36), a receptor that shows no upregulation in the brains of cerebral malaria 
patients. Yet, the dissociation rates are nearly the same for both iRBC-receptor interactions. Thus, our 
results suggest that ICAM-1 may not be the sole mediator responsible for cytoadhesion in the brain.
Of the five Plasmodium (P.) genus parasites known to cause malaria in humans, P. falciparum contributes most 
to severe disease and deaths1, 2. Infection is initiated when an infected female Anopheles mosquito injects sporo-
zoites into the human skin during a blood meal3, 4. After traveling to and replicating within liver cells, merozoites 
are then released into the circulatory system where they invade the red blood cells (RBCs). These merozoites 
then undergo asexual development from ring to trophozoite to schizont stages within 48 hours. At the end of 
each cycle, merozoites are released by the schizonts to invade even more uninfected RBCs. Clinical symptoms 
of malaria – such as chills and fever – present themselves during this asexual blood cycle. To escape the host’s 
splenic clearance system which removes damaged or aged erythrocytes, the parasite employs a sequestration 
strategy5, 6. This process involves the adhesion of parasite-exported proteins, known as ligands, expressed on 
the infected RBC (iRBC) membrane to receptors on host cells3. iRBCs can either bind to endothelial cells7, form 
rosettes with uninfected RBCs8, 9, or cluster amongst themselves via platelet interactions10. Sequestered iRBCs 
occlude microvasculature11, 12, induce the release of damaging inflammatory mediators13, and cause disruptions 
to host metabolism14. Cerebral malaria, a lethal manifestation of P. falciparum, occurs when iRBCs sequester in 
the microvasculature in the brain15.
In a histological study conducted by Turner et al., endothelial activation in fatal cases of cerebral malaria was 
investigated16. Results show that two endothelial receptors, Intercellular Adhesion Molecule 1 (ICAM-1) and 
Cluster of Differentiation 36 (CD36), were present in high amounts in the liver, spleen, kidney, lung and mus-
cle vasculature of infected cases. However, only ICAM-1 was highly expressed in the brains of infected cases16. 
Another clinical study noted a positive correlation between ICAM-1 binding ability and cerebral malaria17. Flow 
assays later demonstrated that iRBCs predominantly roll on ICAM-1 coated substrates but form static adhesions 
with CD3618. These observations led to the hypothesis that ICAM-1 initiates rolling while CD36 stabilizes the 
iRBC thereafter18, 19. Consequently, studies have been conducted to use the soluble forms of these two endothe-
lial receptors to block parasitic domains on the iRBC membrane. CD36 peptides were found to be able to block 
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cytoadhesion of iRBCs as expected20. Intriguingly, iRBC adhesion to ICAM-1 is not always affected in the pres-
ence of soluble ICAM-121.
These findings led us to raise several questions about ICAM-1 mediated sequestration in cerebral malaria: 
Why does ICAM-1 mediate the rolling of iRBCs? Why is soluble ICAM-1 unable to prevent iRBC adhesion unlike 
soluble CD36? What is the strategy employed by the parasite to sequester in ICAM-1 upregulated cerebral micro-
vasculature? Here, we utilize a biophysical approach to tackle these questions. The binding of iRBCs to ICAM-1 
are first probed at a single molecule level to provide us with a fundamental understanding of iRBC-ICAM-1 
interactions. Next, to translate these single bond observations to a cellular level involving multiple bonds, we 
conducted flow experiments to study how clusters of bonds behave. Theoretical modeling was then employed 
to extract association and dissociation parameters of iRBC-ICAM-1 interactions for quantitative analysis. As a 
comparison, the same studies were repeated for iRBC-CD36 bonds. Results from these experiments can help us 
better understand the strategies employed by P. falciparum parasites to enhance iRBC sequestration in the brain.
Results
Single Bond Force Spectroscopy. We first utilized force spectroscopy to study iRBC-ICAM-1 bonds at 
the single molecule level. Since the most basic form of interaction was studied, results obtained were considerably 
less complex to analyze22. There are three different types of interactions that can be formed between a receptor-li-
gand pair: slip bonds, catch bonds and ideal bonds. A slip bond is one which breaks at a faster rate when an exter-
nal force is applied to it23. Such bonds are typically formed in most biomolecular interactions such as aptamers24 
and cell adhesion proteins25. A catch bond, on the other hand, is one that takes an increasing amount of time to 
dissociate when subjected to an increasing force23. Leukocytes can form catch bonds via L-selectin with P-selectin 
glycoprotein ligand-1 (PSGL-1), enabling them to roll along the vasculature above a shear threshold26. FimH 
on Escherichia coli bacteria can also bind to mannose via catch bonds to adhere in a “stick-and-roll” manner27. 
Last but not least, the lifetime of an ideal bond is independent on the force acting on it23. This bond was recently 
observed experimentally by Rakshit et al. in e-cadherin adhesion28. Prior force spectroscopy experiments on 
CD36-iRBC interactions suggest that it forms a slip bond with iRBCs29, 30. Considering that iRBCs were observed 
to remain adhered to ICAM-1 surfaces at high wall shear stress18, we hypothesize that iRBCs bind to ICAM-1 via 
catch bonds.
Bio-Lever atomic force microscope (AFM) tips were functionalized using a protocol similar to that developed 
by Rakshit et al.28 (Fig. 1a). Briefly, it involves biotin-streptavidin interactions as well as the use of a polyethylene 
glycol (PEG) linker. Human recombinant ICAM-1 was then bound to the free end of the PEG linker. The func-
tionalized tip was subsequently used to probe each late stage iRBC in a grid pattern. As depicted in Fig. 1b, each 
cycle involves contacting the iRBC before retracting to a constant set point. The tip was held there for 10 s for any 
formed bonds to break. Thereafter, it was further retracted to break any remaining bonds. Only curves with one 
breaking event during the 10 s constant force period were analyzed by measuring the breaking force and bond 
Figure 1. Single bond force spectroscopy experiment. Panel a: Functionalization of AFM tip. Panel b: 
Schematic of force spectroscopy protocol corresponding to the time scale in panel c. Panel c: Force curve 
depicting the dissociation of a single bond. Lifetime t and breaking force F of a single bond can be measured as 
indicated by the arrows.
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lifetime (Fig. 1c). For most adhesion events to be mediated by single bonds, it is necessary to maintain a binding 
frequency that is less than 20%31. In addition to optimizing the concentration of receptors functionalized on the 
AFM tip, the contact time and approach force were adjusted during the experiment to ensure low adhesion fre-
quency. Numerous measurements over a range of forces were obtained22, 32 to account for the random nature of 
the bond breaking process33. The same process was repeated with CD36 for comparison.
Data obtained from both iRBC-ICAM-1 and iRBC-CD36 interactions were pooled and binned into bin 
widths of 1–2 pN. Considering that our experiments only involve the breaking of single bonds, the probabilistic 
model for small system kinetics34 can be simplified to give
= − .
dP
dt
k P (1)off
m
The above equation describes the rate of change of probability P of finding a bond between the iRBC and 
receptor on the AFM tip at time t. The dissociation rate is given by the constant koff while m is the order of the 
kinetics. Assuming that a first order kinetics is involved in the iRBC interaction with ICAM-1 and CD36, this 
equation can then be analytically solved to obtain
=
−
P e
Z
, (2)
k toff
where Z is a normalization factor. To ascertain this, we plot the natural log of the number of events with a lifetime 
greater than t against t to obtain the survival probabilities of the bonds within each force bin. A straight line with a 
negative gradient is expected for a receptor-ligand interaction with first order kinetics, whereby bond lifetime can 
then be taken to be the inverse of the dissociation constant koff. Figure 2a and b show the survival probability plots 
at three forces for iRBC-ICAM-1 and iRBC-CD36 bonds respectively. Considering that the data points generally 
fit along a straight line, it is likely that both interactions are of first order.
It was observed that a few points diverged from the trend and they occur mostly at longer lifetimes. Reasons 
for deviation could possibly be due to non-specific binding, thermal drifting or simultaneous breaking of mul-
tiple bonds35 even though measures have already been put into place. For instance, adding bovine serum albu-
min (BSA) into the medium or using linkers to functionalize the tip can reduce non-specific binding23. Control 
experiments conducted to measure RBC-ICAM-1 and RBC-CD36 interactions yielded insignificant number of 
lifetimes. Adhesion frequency between iRBC and each receptor was also deliberately reduced to less than 20% 
to ensure that most breaking events were due to single bonds31. More importantly, each bin contains at least 50 
bonds to represent the stochastic nature of bond dissociation in a more accurate manner36. Hence, instead of 
filtering out these seemingly anomalous data, we employ a robust bi-square fitting using Matlab to assign more 
weight to the points that are closest to the general trend and lesser weight to those further away from the trend. 
This method was verified to be consistent with the models used to fit the experimental data, further supporting 
that first order binding kinetics are involved in both iRBC-ICAM-1 and iRBC-CD36 bonds.
After establishing that both interactions were of first order kinetics, we subsequently proceeded to fit our 
experimental data to existing models. The model describing the dissociation rate koff for slip bonds was proposed 
by Bell37 and later theoretically supported by Evans and Ritchie38 with
= .βk k e (3)off
s s Fx0
In this model, ks is the spontaneous dissociation rate i.e. =k koff
s s when the constant force F acting on the bond is 
zero. The inverse temperature β =
k T
1
B
, where kB represents the Boltzmann constant and T is the thermodynamic 
temperature. Finally, x0 denotes the stress-free bond length.
On the other hand, the dissociation rate for catch bonds were described by Dembo et al.39 as
= .
β
κ κ λ− −k k e (4)off
c c y2 ( )( )ts
2
Here, the ligand-receptor bond is considered to be a Hookean spring with stiffness κ. The catch bond kinetics 
undergoes a transition state with stiffness κts and λ is the stress-free length of the bond. It is assumed that the 
ligand-receptor bond obeys Hooke’s law and thus the external stretching force F = −(κ − κts)(y − λts). Therefore, 
after appropriately substituting variables, we obtain the dissociation rate in terms of the force as
= .β ξ−k k e (5)off
c c F F( )0
2
The force F0 = −(κ − κts)(λ − λts) is the characteristic force at which the bond switches from catch to slip bond 
behavior and ξ =
κ κ−
1
2( )ts
 is the inverse effective spring constant. Above, kc is the dissociation rate when F = F0. 
Catch bond behavior can also be described by alternate models40, 41, of which the two-pathway model can be 
supported by Kramers’ rate theory42. In our study, we do not have a structural basis to elucidate the conforma-
tional changes at sub-molecular levels. It is hence impossible for us to ascertain which one of these several models 
holds for the iRBC-ICAM-1 bond pair40. Thus, our goal here was not to validate the type of catch-bond mecha-
nism but rather, to show that the iRBC-ICAM-1 interaction exhibits catch bond behavior. Consequently, we chose 
the Dembo model described above as it contains the minimum number of independent parameters to describe a 
Gaussian, which is observed from the experimental data.
Since the iRBCs interact with both receptors to form bonds that obey first order kinetics, Equations (3) and (5) 
can then be re-written in terms of the lifetime τ of the bond as
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τ = β−
k
e1 (6)s
Fx0
and
τ = .β ξ− −
k
e1 (7)c
F F( )0
2
Graphs of lifetime against force were plotted and fitted into these models to quantitatively understand the 
parameters involved in the bond kinetics. Lifetimes are represented as mean ± standard error of mean (SEM). 
As we have hypothesized, iRBCs form catch bonds with ICAM-1 depicting a distinct peak at the force F0, and 
slip bonds with CD36 showing a clear exponential decay of the lifetime as a function of the force (Fig. 2c and d). 
The fitting parameters are summarized in Table 1. By overlaying the lifetime plots of the iRBC-ICAM-1 
and iRBC-CD36 interactions in Fig. 2e, we find the lifetime of iRBC-CD36 significantly higher than that of 
iRBC-ICAM-1 at low forces (<7 pN) and vice versa in the intermediate range of forces (11–15 pN).
Multiple Bond Flow Assay. While meaningful insights were gained from the single bond force spectros-
copy findings, it is important to note that multiple bonds are formed physiologically. Consequently, we designed 
a flow assay to study multiple bond interactions between iRBCs and the two endothelial receptors (Fig. 3a). 
A straight channel with a rectangular cross section was utilized for flow assays (500 µm × 27.6 µm × 1.5 cm). 
Standard soft lithography techniques were employed in the fabrication of the channels. Prior to the experiment, 
Figure 2. Single bond force spectroscopy results. Panels a and b: Survival probability plots of iRBC-ICAM-1 
and iRBC-CD36 bonds respectively. Panels c and d: Lifetime against force graphs of iRBC-ICAM-1 and 
iRBC-CD36 interactions fitted to the catch and slip bond models. Lifetimes are represented as mean ± SEM. 
Panel e: Combined plots of panels c and d. Student’s t-test was conducted to compare the lifetimes of the two 
interactions within each force bin (**p < 0.01, *p < 0.1).
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channels were functionalized either with 50 µg/ml ICAM-1 or 2 µg/ml CD36 using a protocol similar to Xu et al.30. 
After ensuring that the serological pipette was vertically aligned, the enriched iRBC suspension was then added at 
the inlet and the volume of liquid in the serological pipette corresponding to no flow was determined. Thereafter, 
the liquid volume in the serological pipette was reduced to create a negative pressure at the outlet (a decrease in 
0.1 ml corresponds to an increase in shear stress by 0.007 Pa). The center portion along the length of the channel 
was observed for all experiments. The duration when each cell attached on the substrate was manually measured 
using a stopwatch. Next, the volume of liquid in the serological pipette corresponding to no flow was determined 
again before taking more measurements at other shear stresses. The same batch of enriched iRBCs was used to 
flow in both the ICAM-1 and CD36 coated channels on the same day. Timings were recorded with a precision of 
0.1 s to account for human reaction time and the same experimenter did all the recording for consistency.
As illustrated in the time lapse images in Fig. 3b, the measurement begins when the iRBC becomes stationary 
and stops when the iRBC starts moving again. Since it was unclear if tumbling cells were simply near the substrate 
or interacting with it, measurements did not involve fast rolling cells interacting with the substrate. Measurements 
were not done for cases where: 1) an incoming cell came into contact with the stationary cell, 2) the cell adhered 
for more than 2 min, 3) the cell rolled out of the field of view. Similar to the single bond force spectroscopy exper-
iments, at least 50 data points per shear stress were obtained to account for the stochastic nature of the bond 
breaking process.
In order to connect the single bond force spectroscopy data to the multiple bond flow experiments, we 
extended the work of Efremov and Cao43 to the catch bond scenario and assumed that within the contact area of 
Parameter Unit ICAM-1 CD36
Spontaneous dissociation rate, 
kx (AFM) s
−1 0.3192 0.3095
Stress free bond length, x0 
(AFM) nm — 0.0613
Inverse effective spring 
constant, ξ (AFM) nm·pN
−1 0.0263 —
Characteristic force, F0 (AFM) pN 13.87 —
Temperature, T K 298 298
Association rate, kon
x  (Flow) s−1 0.133 1.22
Protein cluster size, N (Flow) 7 2
Cell radius, r (Flow) μm 3.5 3.5
Viscosity, η Pa·s 0.001 0.001
Effective number of bonds 
times the width of the rupture 
area, σ · a · b · c (Flow)
μm 15.97 2.39
Table 1. Fitting parameters for AFM and flow assay.
Figure 3. Multiple bond flow experiment. Panel a: Schematic of flow experiment set-up. Panel b: Time lapse 
image of infected red blood cell adhering in the flow chamber. Each image corresponds to a time difference of 
200 ms.
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the cell, there is a rupture area wherein all the bond kinetics occur. In most of the contact areas, the bonds will be 
compressed due to the weight of the cell and hence these regions do not significantly contribute to the adhesion 
kinetics. We also assumed that the cell either attaches or detaches and there is no rolling velocity. Thus, within 
these assumptions, the lifetime of the cluster can be obtained as (see Methods section for more details),
τ = −






.
−
k
N
N
k
k
f1 ( 1)!
(8)N
x
x
on
x
x
N
N
x
1
The function fN
x  depends on the type of bond (x = s corresponds to slip bond and x = c to catch bond) and the 
number of bonds N in the rupture area. We assume that the association rate kon
x  for both types of bonds is inde-
pendent of force F, consistent with Bell’s assumptions37. In the case of slip bonds,
∑β=



−




=
f Q x
i
exp 1
(9)N
s
i
N
0
1
and in the case of catch bonds,
∑β ξ=





−
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
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−

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2
Above the effective force Q acting on each site is given by,
pi
σ
τ≈ . .Q r
abc
28 4
(11)w
3
where σ is the effective density of ligands or receptors (whichever is dominant), b and c are the length and width 
of the rupture area respectively, r is the radius of the cell, and a is the width of the contact area (we consider the 
contact area and the rupture area share the same length b). Thus, using Equations (8), (9), (10), and (11) we can 
obtain the lifetime of the cell. Clearly, the lifetime of the cell depends on the single bond parameters (kx, βx0, βξ 
and F0) thereby connecting the single-bond force spectroscopy to the multi-bond flow assay. The fitting parame-
ters from the flow assay are presented in Table 1.
As shown in Fig. 4a and b, the plots of lifetime against shear stress for both iRBC-ICAM-1 and iRBC-CD36 
interactions obtained from flow experiments follow similar trends as the single bond lifetimes. The solid lines 
represent the theoretical results obtained by fitting Equations (8), (9), (10), and (11) to the experimental data 
using a bi-square fit, similar to the single bond force spectroscopy. A characteristic peak is observed at a shear 
stress of about 21 mPa for ICAM-1 while an exponential decay in lifetime is also present for CD36. Studies have 
reported enhanced avidity by flow44, 45, which could possibly explain the increasing lifetime with increasing shear 
stress for ICAM-1. However, these findings were unable to explain the part of the curve above 21 mPa where the 
lifetime decreases. Flow enhanced avidity was also not observed with CD36 even though iRBCs from the same 
culture were used. In other words, the differences between Fig. 4a and b are most likely accrued to the different 
interactions between the iRBC and endothelial receptors – catch versus slip bonds – rather than factors arising 
from the flow.
Even though more bonds are engaged in the iRBC-ICAM-1 interactions than iRBC-CD36 ones, it is evident 
that the lifetimes of the bonds formed with ICAM-1 are lower than those formed with CD36 over the entire range 
of flow rates tested. The hypothesis about the cooperation of CD36 and ICAM-1 in stabilizing iRBCs at different 
shear rates does not seem likely based on these results. This phenomenon can be explained by the much lower kon 
for ICAM-1 than CD36. We also noticed the lower binding affinity of the iRBCs to ICAM-1 when optimizing the 
respective concentrations of receptors used for coating the channel whereby, the concentration of ICAM-1 used 
Figure 4. Multiple bond flow experiment results. Panel a: Lifetime against shear stress graphs of iRBC-ICAM-1 
interactions fitted to the multiple catch bond model. Panel b: Lifetime against shear stress graphs of iRBC-CD36 
interactions fitted to the multiple slip bond model. Lifetimes are represented as mean ± SEM.
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to coat the flow channel was 25 times that of CD36. Together, these findings show the importance of considering 
both association and dissociation parameters in understanding the kinetics of a ligand-receptor pair.
Discussion
The first question that comes to mind is: what are the implications of iRBC-ICAM-1 catch bond interactions? 
Firstly, the dynamics of catch bonds can only be observed over a range of forces. It is hence essential for studies 
involving iRBC-ICAM-1 interactions to be conducted over a range of shear rates for a more accurate representa-
tion of adhesive strength and affinity. Next, just like how leukocytes26 and bacteria27 are able to form catch bonds 
that mediate rolling and are enhanced in the presence of a force, iRBC-ICAM-1 interactions behave similarly. 
Our results explain the observations from in vitro flow assays that have shown that ICAM-1 mediates rolling of 
iRBCs as well as the ability of iRBCs to remain adhered to ICAM-1 at high shear rates18. Even though the lifetime 
of individual bonds do not scale linearly with an increase in number of bonds, our force spectroscopy results 
support the commonly accepted hypothesis that ICAM-1 mediates rolling and adhesion stability at high shear 
rates while CD36 stabilizes the iRBC at lower shear rates18, 19. We further propose that this catch bond interaction 
sheds light on why soluble ICAM-1 is unable to block adhesion to iRBCs unlike soluble CD36. Bearing in mind 
that catch bonds have increased lifetimes only when external force is applied, iRBC-ICAM-1 bonds tend to dis-
sociate rapidly when free-floating soluble ICAM-1 interacts with the iRBC due to the absence of forces acting on 
the receptor-ligand pair. This scenario is unlike the case when ICAM-1 is anchored in position by the endothelial 
cell, whereby blood flow will exert a force on the iRBC-ICAM-1 bonds. Moreover, high levels of soluble ICAM-1 
in the plasma and brain are correlated with the severity of malaria46, 47. It is hence advantageous for iRBCs to 
form catch bonds with ICAM-1 as a sequestration strategy to avoid being affected by the high amounts of soluble 
ICAM-1 present in the brain.
Interestingly, the subsequent flow experiment and modeling work seemed to suggest that ICAM-1 alone may 
not be able to account for the accumulation of iRBCs in the brain due to the short adhesion lifetimes as well as 
low association rates. This discrepancy between the flow results and force spectroscopy findings led us to question 
the significance of ICAM-1 in contributing to sequestration in cerebral malaria. ICAM-1 upregulation is the only 
endothelial receptor known to have a positive correlation with cerebral malaria. Yet, the low association affinity 
between iRBC and ICAM-1 suggests that ICAM-1 may not be able to stabilize the binding for sequestration to 
occur. Could other receptors like CD36 be involved in cerebral malaria too? Despite having very low levels of 
CD36 expression in the brain, significant co-localization of sequestration was observed with CD36, ICAM-1 
and E-selectin in cerebral vessels16. The comparatively higher association affinity of CD36 and our lifetime meas-
urements indicate that it is not necessary for high amounts of this receptor to be present to stabilize the binding 
of iRBCs. Furthermore, platelets have been shown to bind to endothelial cells and mediate binding of iRBCs, of 
which CD36 is one of the potential receptors involved48, 49. Hence, it is likely that ICAM-1 is not solely responsible 
for all the sequestration in cerebral vasculature.
The 3D7 strain used in our study was selected for ICAM-1 and may not be an accurate representation of the 
interactions occurring in cerebral malaria. P. falciparum Erythrocyte Membrane Protein-1 (PfEMP1) family com-
prises antigenically variable proteins expressed on the iRBC membrane that can mediate cytoadhesion to host 
cells via receptors such as ICAM-1 and CD3650. The antigenic diversity of PfEMP1 (regulated by approximately 60 
var genes per parasite genome51) enables the malaria parasite to avoid the host’s immune system and prolong the 
duration of infection52. Based on genetic organization, chromosomal location and strain structure, researchers 
were able to classify these var genes into three groups53. However, conflicting results have been reported on the 
relationship between each group and cerebral malaria51. The selection for ICAM-1 may result in a mixture of dif-
ferent groups of PfEMP1 expressed across the cells used in our experiments. As a result, the findings in our study 
are relevant to iRBC-ICAM-1 interactions in general but may not be specific to those involved in cerebral malaria. 
Flow experiments were limited to a small bond cluster size, via reducing the receptor concentration for coating 
the substrate, as well as low shear rates to enable the observation of cells binding and detaching. Furthermore, as 
we were unable to discern between cells tumbling near the substrate and cells rolling due to interaction with the 
substrate, our flow experiments only captured a subset of the iRBC-receptor interactions. It is hence noteworthy 
that our multiple bond data does not involve rolling, which may be essential under physiological conditions.
Nonetheless, our work provides a fresh insight into this longstanding biological problem. The systematic study 
of iRBC-ICAM-1 bonds from single molecule to multiple bonds enabled us to understand detailed bond kinetics 
by first probing the fundamental interactions. Such an approach will also be useful in directly determining the 
nature of other iRBC-receptor interactions that behave like catch bonds under flow conditions. For instance, 
recent hydrodynamic experiments by Rieger et al. have suggested catch bond interactions between VAR2CSA 
encoded by the iRBC and chondroitin-4-sulfate (CSA) expressed on placental proteoglycans54. Computational 
modeling further empowered us to extract quantitative parameters that can be utilized for comparison with 
other iRBC-receptor interactions such as iRBC-CD36 bonds as presented in this paper. Moreover, iRBC-receptor 
dynamics can also be simulated using these experimentally obtained parameters to probe deeper into the inter-
actions in future studies.
Conclusions
Here, we used a biophysical approach to study iRBC-ICAM-1 interactions at both the single molecule and mul-
tiple bond level. Force spectroscopy results showed that ICAM-1 forms catch bonds with iRBCs unlike CD36, 
which forms slip bonds. Our findings highlighted the importance of conducting flow assays over a wide range 
of flow rates to fully capture the adhesion of iRBCs to ICAM-1. We were also able to understand why ICAM-1 
is able to mediate the rolling of iRBCs as well as propose a reason as to why soluble ICAM-1 is not as effective in 
preventing iRBC-ICAM-1 adhesion. However, to better understand these interactions in a more physiologically 
relevant manner, flow experiments were conducted to study multiple bond behavior. We subsequently proposed 
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a computational model that could capture the lifetime of the cells exhibiting catch bond behavior under flow 
conditions and enable us to extract bond association parameters. Interestingly, while dissociation constants are 
similar, the association constant for iRBC-ICAM-1 bonds is ten times lower than iRBC-CD36 bonds. This result 
suggested that ICAM-1 may not be the sole mediator of sequestration in cerebral malaria and it is likely that, 
despite its low level of expression in brain microvasculature, CD36 is involved too.
Methods
Parasite culture. Laboratory adapted P. falciparum 3D7 knob- positive strain was used in these experi-
ments29. Parasites were cultured in vitro with human erythrocytes (informed consent from donors obtained) 
using a protocol developed by Trager and Jensen55. Briefly, malaria culture medium (MCM) was prepared by sup-
plementing RPMI 1640 (Invitrogen) with 0.5% Albumax II (Invitrogen), 50 µg/ml hypoxanthine (Sigma Aldrich), 
2 mM L-glutamine (Sigma Aldrich) and 25 µg/ml gentamycin (Gibco Life Technologies). Parasites were cultured 
at 2.5% hematocrit and incubated at 5% CO2, 3% O2 and 92% N2 at 37 °C. Synchronization of culture was achieved 
using 5% sorbitol when majority of the infected cells were in the ring stage. Parasitemia was determined by 
observing Giemsa-stained blood smears under a microscope at 100x magnification.
iRBC Enrichment. iRBCs in the schizont stage contain paramagnetic iron in the hemozoin, allowing them 
to be separated from the initial culture using magnetic-activated cell sorting (MACS)56. In our experiments, 
the LD column (MiltenyiBiotec) and SuperMACS II Separator (MiltenyiBiotec) were used to enrich late stage 
iRBCs. The LD column was first inserted into the separator before rinsing with MCM. Subsequently, the culture 
suspension was added and subjected to the magnetic field from the SuperMACS II Separator. MCM was added to 
the column at least thrice to ensure that the uninfected and ring stage erythrocytes were rinsed out of the system. 
To collect the late stage iRBCs, the column was first removed from the separator and placed in a clean collection 
tube. 4 ml MCM was added twice to elute all iRBCs in the column. The resultant cell suspension was then centri-
fuged at 600 g for 5 min before removing the supernatant. Finally, the cell pellet was re-suspended in MCM to an 
appropriate concentration for experiments. The amount of late stage iRBCs obtained after enrichment is generally 
above 80%.
ICAM-1 selection. P. falciparum 3D7 parasites were selected for adhesion to ICAM-1. A 22 mm diameter 
cover slip was first rinsed with 70% ethanol before dipping into de-ionized (DI) water. After the cover slip has 
been dried, it was placed in a 6-well plate and plasma treated for 10 min. The 6-well plate was subsequently 
placed in the biosafety cabinet and treated with ultraviolet (UV) radiation for 30 min. 100 μl of 100 μg/ml ICAM-1 
protein was added to the cover slip before sealing the plate with parafilm and incubating overnight at 4 °C. 1x 
Phosphate Buffered Saline (PBS) was used to wash the ICAM-1 cover slip the following day. Next, the surface was 
incubated with 1% Bovine Serum Albumin (BSA) (Miltenyi Biotec) for 30 min to reduce non-specific binding. 
The cover slip was rinsed with PBS before adding enriched iRBCs and incubating in the malaria culture incuba-
tor for 1 hour. Unbound iRBCs were washed with RPMI for more than five times. Finally, 5 ml malaria culture 
medium and 250 μl of fresh RBC pellet were added into the well for continuous culture over the next few days. 
When the selected parasite parasitemia reached more than 5%, a second selection was performed. The expanded 
culture was aliquoted and frozen for future experiments.
Force spectroscopy substrate preparation. The substrate for force spectroscopy was prepared by 
first washing a 30 mm diameter cover slip with ethanol. Thereafter, the cover slip was dipped into DI water 
and dried in the oven. It was then plasma treated for 10 min before adding 300 μl of 50 µg/ml Phaseolus 
vulgaris-Erythroagglutinin (PHA-E) (Vector Laboratories). This lectin is known to have high affinity to glyco-
phorin on human erythrocytes57. After incubating for an hour, the cover slip was washed thrice with 1 x PBS. 
Magnetically enriched late stage iRBCs were subsequently added to it and incubated for 30 min at room tempera-
ture. Unbound iRBCs were removed by washing the cover slip with MCM thrice. Finally, the cover slip was stuck 
onto the lid of a 60 mm diameter petri dish using adhesive before filling the lid with 1% BSA in MCM to reduce 
non-specific adhesion of cellular debris to the atomic force microscope (AFM) tip.
AFM tip functionalization. Gold coated Bio-Lever AFM tips (Olympus) utilized in force spectroscopy 
experiments were functionalized using a protocol similar to that developed by Rakshit et al.28. The tip was first 
plasma treated for 15 min before incubating with 10 μl of 1 mg/ml BSA-Biotin (Sigma Aldrich) overnight at 
4 °C in a humidified chamber. On the following day, the tip was then incubated with 10 μl of 10 µM streptavi-
din (ThermoFisher Scientific) for 30 min before immersing the tip in 200 µl of 10 mg/ml NHS-PEG4-Biotin 
(ThermoFisher Scientific) for another 30 min. The tip was subsequently incubated with 10 μl of human ICAM-1 
protein (100 µg/ml) and CD36 (66 µg/ml) (Sino Biological Inc.) for an hour. Lastly, additional activated amine 
groups were blocked by incubating with 1 mg/ml glycine (Sigma Aldrich) for 30 min. Tips were rinsed with 
1 × PBS after each incubation step.
Force spectroscopy. The functionalized Bio-Lever AFM tip was first mounted onto the JPK NanoWizard II 
and subsequently placed on the stage of the Olympus IX81 microscope. The longer cantilever (100 µm × 30 µm) 
was then calibrated in situ using thermal fluctuation analysis in-built in the JPK SPMControl Software v.4. Spring 
constants ranged from 2–12 pN/nm. Next, the cantilever was placed above an iRBC which was then probed 
repeatedly in a grid pattern. In each cycle, the tip of the cantilever approached the cell at a constant speed of 
1.5 µm/s and was immediately held there for 50–200 ms to allow for bond formation. Thereafter, it retracted at 
250 nm/s to a force between 0–25 pN and maintained at the same force for 10 s. The tip was then retracted at a 
rate of 2 µm/s to break all remaining bonds before approaching the next location on the iRBC. For most adhesion 
events to be mediated by single bonds, it is necessary to maintain a binding frequency that is less than 20%31. 
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In addition to optimizing the concentration of receptors functionalized on the AFM tip, the contact time and 
approach force was also adjusted during the experiment to ensure low adhesion frequency.
JPKSPM Data Processing software was utilized to process the raw data. A 1.00 Gaussian smoothing filter was 
first applied to all the curves to better identify of low force breaking events. Next, the “automatically subtract 
baseline” function was used to correct the baseline to 0 pN. Only curves with one breaking event during the 10 s 
constant force period were analyzed by measuring the breaking force and time where force is constant. All the 
data were pooled and binned into bin widths of 1–2 pN. Each bin contains at least 50 lifetimes.
Flow channel fabrication. A straight channel with a rectangular cross section was utilized for flow assays. 
The master mold was made by patterning the 2D image of the channel on a silicon wafer using 27.6 µm thick SU-8 
photoresist and standard photolithography methods. This mold was then silanized by vaporizing 60 µl of trichloro 
(1H,1H,2H,2H-perfluoro-octyl) silane (Sigma-Aldrich) for 8 min before allowing it to settle down on the sili-
con wafer for 30 min. Subsequently, the polydimethylsiloxane (PDMS) pre-polymer base and cross linking agent 
(Dow Corning) were mixed 10:1 by weight and poured over the mold. The mold was then left in the desiccator to 
remove all the bubbles in the mixture before curing in the oven for 2 h at 80 °C. After the PDMS is fully cured, it 
is released from the mold and cut out the individual channels before punching holes at the inlet and outlet. The 
underside of the channel and a clean cover glass were then plasma treated before binding them together. Finally, 
the bonded channels were placed in the oven for 2 h at 80 °C.
Flow channel functionalization. Flow channels were functionalized using a protocol similar to Xu et al.30.
To prevent the entry of bubbles, the flow channel was first primed with 70% ethanol. The channel was then 
washed with 1 × PBS before filling it with either 2 µg/ml CD36 or 50 µg/ml ICAM-1. Next, it was sealed in a 
humidified chamber and incubated overnight at 4 °C. After washing with PBS the next day, the channel was filled 
with 5% BSA in PBS and incubated for 1 h at room temperature. The channel was then washed with PBS just 
before the experiment.
Flow experiment. Prior to the experiment, a spirit level was used to ensure that the serological pipette was 
vertically aligned. The enriched iRBC suspension was then added at the inlet and the volume of liquid in the 
serological pipette corresponding to no flow was determined by using the syringe. Thereafter, the liquid volume 
was reduced by 0.2 ml (equivalent to an increase in shear stress by 0.014 Pa). The center portion along the length 
of the channel was observed. The duration when each cell attached on the substrate was manually timed using a 
stopwatch up to 2 min. Next, the volume of liquid in the serological pipette corresponding to no flow was deter-
mined again before reducing the volume by 0.3, 0.4, 0.5 and 0.6 ml respectively for further measurements to be 
taken. The same batch of enriched iRBCs was used to flow in both the ICAM-1 and CD36 coated channels on the 
same day.
Modeling the adhesion lifetime in flow. Following the work of Efremov and Cao43, we first expressed 
the shear rate in terms of the force experienced by each bond in the rupture area. We simplified the contact area of 
the cell as a rectangle with width b and length a. Within this small contact area, we further assume that there is a 
rupture area that contains most of the bonds and effectively governs the lifetime of the cell. Thus, the total tension 
Qtot experienced by all adhesion sites is:
= ⋅Q K Q, (12)tot
where Q is the effective force acting on each site and K = σbc is the number of bonds in the rupture area with σ 
being the effective density of receptors or ligands (whichever is dominant). By solving the mechanical equilibrium 
equations similar to those by Hammer et al.58 under the assumption that the cell is either attached or detached, 
i.e., rolling velocity v ≈ 0 we obtain,
pi
τ≈
.Q r
a
28 4 , (13)tot w
3
where r is the radius of the cell and τw is the shear stress. Therefore, the force Q experienced by each bond can be 
expressed in terms of the shear stress τw as,
pi
σ
τ≈
.
.Q r
abc
28 4
(14)tot w
3
It is worth noting here that our aim is simpler than that of Efremov and Cao43. In their work, they were inter-
ested in finding a relation between the cells velocity and the shear rate. In our case we would like to construct a 
simplistic model relating the shear rate to the tension experienced by a single adhesion bond, when the rolling 
velocity of the cells v ≈ 0. The above description of the tension Q is not constrained by the bond behavior and 
hence could describe catch and slip bonds. Similar to the work of Erdmann and Schwarz36, 59 the adhesion of a 
cluster can be represented as a chain reaction,
− →   N N 1 2 1 0,
where the right pointing arrow denote the dissociation rate ki,i−1 of going from i to i − 1 and the left-pointing 
arrow denotes the association rate ki−1, i of going from i − 1 to i. The state 0 denotes all bonds being detached in 
the cluster and hence there is no association rate from state 0 to 1. The average lifetime of a single adhesion site 
can be obtained by calculating the mean turn-over time60, 61 for the chain as,
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1
, 1 1 , 1. The exact expression for the lifetime Eq. (15) can be further 
simplified as Eq. (8) when the shear stress τw is low (⇒Q is low), i.e., + +k ki i i i, 1 1, , where ∈ −i N[1, 1]. This 
result agrees very well with the results obtained by Erdmann and Schwarz59.
Ethics statement. Blood donation protocol is approved by the National University of Singapore Institutional 
Review Board. Blood drawing was carried out in accordance with the relevant guidelines and regulations at the 
National University Hospital Blood Donation Centre. Informed consent was obtained from all donors.
References
 1. World Health Organisation. World Malaria Report 2015 (2015).
 2. Snow, R. W., Guerra, C. a., Noor, A. M., Myint, H. Y. & Simon, I. The global distribution of clinical episodes of Plasmodium 
falciparum malaria. 434, 214–217 (2011).
 3. Rowe, J. A., Claessens, A., Corrigan, R. A. & Arman, M. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: 
molecular mechanisms and therapeutic implications. Expert Rev. Mol. Med. 11, e16 (2009).
 4. Sinnis, P. et al. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J. Exp. Med. 180, 
297–306 (1994).
 5. Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5, 606–16 (2005).
 6. Chen, Q., Schlichtherle, M. & Wahlgren, M. Molecular Aspects of Severe Malaria. Society 13, 439–450 (2000).
 7. Udeinya, I. J., Schmidt, J. A., Aikawa, M., Miller, L. H. & Green, I. Falciparum malaria-infected erythrocytes specifically bind to 
cultured human endothelial cells. Science 213, 555–557 (1981).
 8. Handunnetti, S. M., David, P. H., Perera, K. L. R. L. & Mendis, K. N. Uninfected erythrocytes form ‘rosettes’ around Plasmodium 
falciparum infected erythrocytes. Am. J. Trop. Med. Hyg 40, 115–118 (1989).
 9. Singh, H. et al. Expression dynamics and physiologically relevant functional study of STEVOR in asexual stages of Plasmodium 
falciparum infection. Cell. Microbiol. 19, e12715 (2017).
 10. Pain, A. et al. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is 
associated with severe malaria. Proc. Natl. Acad. Sci. 98, 1805–1810 (2001).
 11. Dondorp, A. M. et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J. Infect. Dis. 197, 
79–84 (2008).
 12. Dondorp, A. M., Pongponratn, E. & White, N. J. Reduced microcirculatory flow in severe falciparum malaria: Pathophysiology and 
electron-microscopic pathology. Acta Trop. 89, 309–317 (2004).
 13. Schofield, L. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol. Cell Biol. 85, 130–7 (2007).
 14. Planche, T. & Krishna, S. Severe malaria: metabolic complications. Curr. Mol. Med. 6, 141–153 (2006).
 15. Pino, P., Taoufiq, Z., Nitcheu, J., Vouldoukis, I. & Mazier, D. Blood-brain barrier breakdown during cerebral malaria: Suicide or 
murder? Thromb. Haemost. 95, 715–9 (2005).
 16. Turner, G. D. et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation 
and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol 145, 1057–1069 (1994).
 17. Newbold, C. et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg 57, 389–398 
(1997).
 18. Cooke, B. M. et al. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for 
ICAM-1, CD36 and thrombospondin. Br. J. Haematol. 87, 162–70 (1994).
 19. Gray, C., McCormick, C., Turner, G. & Craig, A. ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium 
under flow. Mol. Biochem. Parasitol. 128, 187–193 (2003).
 20. Baruch, D. I., Ma, X. C., Pasloske, B., Howard, R. J. & Miller, L. H. CD36 peptides that block cytoadherence define the CD36 binding 
region for Plasmodium falciparum-infected erythrocytes. Blood 94, 2121–2127 (1999).
 21. Craig, A. G. et al. Failure to block adhesion of Plasmodium falciparum-infected erythrocytes to ICAM-1 with soluble ICAM-1. 
Infect. Immun. 65, 4580–4585 (1997).
 22. Zhu, C., Long, M., Chesla, S. E. & Bongrand, P. Measuring receptor/ligand interaction at the single-bond level: Experimental and 
interpretative issues. Ann. Biomed. Eng. 30, 305–314 (2002).
 23. Rakshit, S. & Sivasankar, S. Biomechanics of cell adhesion: how force regulates the lifetime of adhesive bonds at the single molecule 
level. Phys. Chem. Chem. Phys. 16, 2211–23 (2014).
 24. Aubin-Tam, M. E. et al. Adhesion through single peptide aptamers. J. Phys. Chem. A 115, 3657–3664 (2011).
 25. Litvinov, R. I. et al. Dissociation of bimolecular αIIbβ3-fibrinogen complex under a constant tensile force. Biophys. J. 100, 165–173 
(2011).
 26. Finger, E. B. et al. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature 379, 266–269 (1996).
 27. Thomas, W. E., Nilsson, L. M., Forero, M., Sokurenko, E. V. & Vogel, V. Shear-dependent ‘stick-and-roll’ adhesion of type 1 
fimbriated Escherichia coli. Mol. Microbiol 53, 1545–1557 (2004).
 28. Rakshit, S., Zhang, Y., Manibog, K., Shafraz, O. & Sivasankar, S. Ideal, catch, and slip bonds in cadherin adhesion. Proc. Natl. Acad. 
Sci. 109, 18815–18820 (2012).
 29. Li, A. et al. Molecular mechanistic insights into the endothelial receptor mediated cytoadherence of Plasmodium falciparum-
infected erythrocytes. PLoS One 6, e16929 (2011).
 30. Xu, X. et al. Probing the Cytoadherence of Malaria Infected Red Blood Cells under Flow. PLoS One 8, 2–9 (2013).
 31. Shao, J. Y. & Xu, G. The adhesion between a microvillus-bearing cell and a ligand-coated substrate: A Monte Carlo study. Ann. 
Biomed. Eng. 35, 397–407 (2007).
 32. Marshall, B. T. et al. Direct observation of catch bonds involving cell-adhesion molecules. Nature 423, 190–3 (2003).
 33. Evans, E. Probing the Relation Between Force—Lifetime—and Chemistry in Single Molecular Bonds. Annu. Rev. Biophys. Biomol. 
Struct. 30, 105–128 (2001).
 34. Piper, J. W., Swerlick, R. a. & Zhu, C. Determining force dependence of two-dimensional receptor-ligand binding affinity by 
centrifugation. Biophys. J. 74, 492–513 (1998).
 35. Evans, E., Halvorsen, K., Kinoshita, K. & Wong, W. P. In Handbook of Single-Molecule Biophysics 70, 571–589 (Springer US, 2009).
 36. Erdmann, T. & Schwarz, U. S. Stability of Adhesion Clusters under Constant Force. Phys. Rev. Lett. 92, 108102 (2004).
 37. Bell, G. Models for the specific adhesion of cells to cells. Science 200, 618–627 (1978).
 38. Evans, E. & Ritchie, K. Dynamic strength of molecular adhesion bonds. Biophys. J. 72, 1541–1555 (1997).
 39. Dembo, M., Torney, D. C., Saxman, K. & Hammer, D. The reaction-limited kinetics of membrane-to-surface adhesion and 
detachment. Proc. R. Soc. London. Ser. B 234, 55–83 (1988).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7: 4208  | DOI:10.1038/s41598-017-04352-x
 40. Zhu, C., Lou, J. & McEver, R. P. Catch bonds: physical models, structural bases, biological function and rheological relevance. 
Biorheology 42, 443–62 (2005).
 41. Chakrabarti, S., Hinczewski, M. & Thirumalai, D. Phenomenological and microscopic theories for catch bonds. J. Struct. Biol. 197, 
50–56 (2017).
 42. Pereverzev, Y. V., Prezhdo, O. V., Forero, M., Sokurenko, E. V. & Thomas, W. E. The Two-Pathway Model for the Catch-Slip Transition 
in Biological Adhesion. Biophys. J. 89, 1446–1454 (2005).
 43. Efremov, A. & Cao, J. Bistability of Cell Adhesion in Shear Flow. Biophys. J. 101, 1032–1040 (2011).
 44. Chen, S. & Springer, T. A. An automatic braking system that stabilizes leukocyte rolling by an increase in selectin bond number with 
shear. J. Cell Biol. 144, 185–200 (1999).
 45. Dwir, O. et al. Avidity enhancement of L-selectin bonds by flow: Shear-promoted rotation of leukocytes turn labile bonds into 
functional tethers. J. Cell Biol. 163, 649–659 (2003).
 46. Turner, G. et al. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular 
endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am. J. Pathol. 152, 1477–87 (1998).
 47. Cserti-Gazdewich, C. M. et al. Combined measurement of soluble and cellular ICAM-1 among children with Plasmodium 
falciparum malaria in Uganda. Malar J 9, 233 (2010).
 48. Grau, G. E. et al. Platelet Accumulation in Brain Microvessels in Fatal Pediatric Cerebral Malaria. J. Infect. Dis. 187, 461–466 (2003).
 49. Wassmer, S. C. et al. Platelets Reorient Plasmodium falciparum –Infected Erythrocyte Cytoadhesion to Activated Endothelial Cells. 
J. Infect. Dis. 189, 180–189 (2004).
 50. Kraemer, S. M. & Smith, J. D. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9, 374–380 
(2006).
 51. Bengtsson, A. et al. A Novel Domain Cassette Identifies Plasmodium falciparum PfEMP1 Proteins Binding ICAM-1 and Is a Target 
of Cross-Reactive, Adhesion-Inhibitory Antibodies. J. Immunol. 190, 240–249 (2013).
 52. Pasternak, N. D. & Dzikowski, R. PfEMP1: An antigen that plays a key role in the pathogenicity and immune evasion of the malaria 
parasite Plasmodium falciparum. Int. J. Biochem. Cell Biol. 41, 1463–1466 (2009).
 53. Kraemer, S. M. & Smith, J. D. Evidence for the importance of genetic structuring to the structural and functional specialization of 
the Plasmodium falciparum var gene family. Mol. Microbiol 50, 1527–1538 (2003).
 54. Rieger, H. et al. Cytoadhesion of Plasmodium falciparum - Infected erythrocytes to chondroitin-4-sulfate is cooperative and shear 
enhanced. Blood 125, 383–391 (2015).
 55. Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science (80-.) 193, 673–675 (1976).
 56. Ribaut, C. et al. Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. 
5, 1–5 (2008).
 57. Liu, F., Burgess, J., Mizukami, H. & Ostafin, A. Sample preparation and imaging of erythrocyte cytoskeleton with the atomic force 
microscopy. Cell Biochem. Biophys. 38, 251–270 (2003).
 58. Hammer, D. A. & Lauffenburger, D. A. A dynamical model for receptor-mediated cell adhesion to surfaces. Biophys. J. 52, 475–487 
(1987).
 59. Erdmann, T. & Schwarz, U. S. Stochastic dynamics of adhesion clusters under shared constant force and with rebinding. J. Chem. 
Phys. 121, 8997–9017 (2004).
 60. Bar-Haim, A. & Klafter, J. On mean residence and first passage times in finite one-dimensional systems. J. Chem. Phys. 109, 5187 
(1998).
 61. Cao, J. & Silbey, R. J. Generic Schemes for Single-Molecule Kinetics. 1: Self-Consistent Pathway Solutions for Renewal Processes. J. 
Phys. Chem. B 112, 12867–12880 (2008).
Acknowledgements
The authors would like to thank Dr Fang Kong and Dr Lipeng Lai for the discussions. They are also grateful for the 
facilities provided by the MechanoBioEngineering Laboratory and the Global Enterprise for Micro-Mechanics 
and Molecular Medicine (GEM4) Laboratory at the National University of Singapore, and the Singapore-MIT 
Alliance for Research and Technology (SMART) Infectious Diseases Program. Y.B.L. is funded by the SMA 
Graduate Fellowship at SMART.
Author Contributions
Y.B.L., J.T., J.C. and C.T.L. conceived and designed the experiments. Y.B.L. performed the experiments. Y.B.L. and 
J.T. analyzed the results. J.T. performed the theoretical modeling. All authors reviewed the manuscript.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
